In addition, inhibiting the RhoA/ROCK pathway may have deleterious effects on neuroinflammation, BBB dysfunction, neuronal apoptosis, astrogliosis, and axonal injury after ischemic stroke. This evidence concerns the gene RHOA and ischemic stroke.